Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
NCT07354516
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
OAG - Open-Angle Glaucoma
OHT - Ocular Hypertension
Interventions
COMBINATION_PRODUCT:
QLS-111-FDC
DRUG:
Latanoprost (0.005%)
Sponsor
Qlaris Bio, Inc.